T-Mobile Falls, MGM Rises, Incyte Gains on Clinical Data
On this episode of Stock Movers:
- T-Mobile (TMUS) shares fall after news that President Donald Trump is launching a Trump-branded mobile phone service, that will rely on wireless networks and hardware that is “made in America.”
- MGM (MGM) shares rise after sports betting joint venture BetMGM raised its net revenue and Ebitda guidance for fiscal year 2025, following strong second-quarter trading.
- Incyte (INCY) shares gain after the drugmaker gave clinical data from two trials of its experimental therapy to treat a blood disorder, which is impressing Wall Street.
See omnystudio.com/listener for privacy information.
You May Also Like

LAMBS TO LIONS
Matt Funk

The Property Academy Podcast
Opes Partners

Marketplace All-in-One
Marketplace

🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen

Cash Daddies With Sam Tripoli, Howie Dewey and Johnny Woodard
Johnny Woodard

CNBC Business News Update
CNBC

The Entrepreneur DNA
Justin Colby, Bleav

Mining Stock Daily
Trevor Hall

Proactive - Interviews for investors
Proactive

Datasets
Visionary
Community discussion